OOIR: Observatory of International Research

Papers

(The H4-Index of Pharmacotherapy is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
	80
Changes in serum potassium in people with type 2 diabetes taking sodium‐glucose co‐transporter‐2 inhibitors	79
Safety and efficacy of cefiderocol for off‐label treatment indications: A systematic review	61
Warfarin dosage in a postpartum woman while breastfeeding: A case report	46
Association of bleeding with serotonergic antidepressants in patients receiving left ventricular assist device support	44
Assessment and management of iatrogenic withdrawal syndrome and delirium in pediatric intensive care units across Europe: An ESPNIC survey	41
Hydroxyurea treatment for sickle cell anemia during pregnancy and lactation: Current evidence and knowledge gaps	40
Update and narrative review of avian influenza (H5N1) infection in adult patients	38
Comparison of risk‐scoring systems for heparin‐induced thrombocytopenia in cardiac surgery patients	33
Treatment of patients with serious infections due to carbapenem‐resistant Acinetobacter baumannii: How viable are the current options?	32
Acid‐suppressive drugs: A systematic review and network meta‐analysis of their nocturnal acid‐inhibitory effect	32
Empiric dosing strategies to predict lamotrigine concentrations during pregnancy	31
Characterization of lamotrigine disposition changes during and after pregnancy in women with epilepsy	30
	29
Role of maternal COVID‐19 vaccination in providing immunological protection to the newborn	26
Impact of concurrent gabapentin or pregabalin with high‐dose melphalan in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant	26
Impact of CYP3A5 phenotype on tacrolimus time in therapeutic range and clinical outcomes in pediatric renal and heart transplant recipients	25
Reduced risk of NSAID‐Induced adverse events with concomitant use of misoprostol (MICRO study)	25
Statin‐associated muscle symptoms—A review: Individualizing the approach to optimize care	25
Reversal of apixaban and rivaroxaban with andexanet alfa prior to invasive or surgical procedures	24
Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution	23
Optimal starting dosing regimen of intravenous oxytocin for labor induction based on the population kinetic‐pharmacodynamic model of uterine contraction frequency	22